This content is from: Patents

Kyle Bass files 15th IPR, targeting patent for Vimovo treatment

The Coalition for Affordable Drugs has filed an inter partes review petition challenging a patent for Pozen’s Vimovo drug, which Horizon Pharma holds the rights to in the US

To access our in-house intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | One Week Trial

Related